Ontology highlight
ABSTRACT: Background and purpose
It has been proposed that BRL37344, SR58611 and CGP12177 activate ??-adrenoceptors in human atrium to increase contractility and L-type Ca(2+) current (I(Ca-L)). ??-adrenoceptor agonists are potentially beneficial for the treatment of a variety of diseases but concomitant cardiostimulation would be potentially harmful. It has also been proposed that (-)-CGP12177 activates the low affinity binding site of the ??-adrenoceptor in human atrium. We therefore used BRL37344, SR58611 and (-)-CGP12177 with selective ?-adrenoceptor subtype antagonists to clarify cardiostimulant ?-adrenoceptor subtypes in human atrium.Experimental approach
Human right atrium was obtained from patients without heart failure undergoing coronary artery bypass or valve surgery. Cardiomyocytes were prepared to test BRL37344, SR58611 and CGP12177 effects on I(Ca-L). Contractile effects were determined on right atrial trabeculae.Key results
BRL37344 increased force which was antagonized by blockade of ??- and ??-adrenoceptors but not by blockade of ??-adrenoceptors with ??-adrenoceptor-selective L-748,337 (1 µM). The ??-adrenoceptor agonist SR58611 (1 nM-10 µM) did not affect atrial force. BRL37344 and SR58611 did not increase I(Ca-L) at 37°C, but did at 24°C which was prevented by L-748,337. (-)-CGP12177 increased force and I(Ca-L) at both 24°C and 37°C which was prevented by (-)-bupranolol (1-10 µM), but not L-748,337.Conclusions and implications
We conclude that the inotropic responses to BRL37344 are mediated through ??- and ??-adrenoceptors. The inotropic and I(Ca-L) responses to (-)-CGP12177 are mediated through the low affinity site ?(1L)-adrenoceptor of the ??-adrenoceptor. ??-adrenoceptor-mediated increases in I(Ca-L) are restricted to low temperatures. Human atrial ??-adrenoceptors do not change contractility and I(Ca-L) at physiological temperature.
SUBMITTER: Christ T
PROVIDER: S-EPMC3042194 | biostudies-literature | 2011 Feb
REPOSITORIES: biostudies-literature
British journal of pharmacology 20110201 4
<h4>Background and purpose</h4>It has been proposed that BRL37344, SR58611 and CGP12177 activate β₃-adrenoceptors in human atrium to increase contractility and L-type Ca(2+) current (I(Ca-L)). β₃-adrenoceptor agonists are potentially beneficial for the treatment of a variety of diseases but concomitant cardiostimulation would be potentially harmful. It has also been proposed that (-)-CGP12177 activates the low affinity binding site of the β₁-adrenoceptor in human atrium. We therefore used BRL373 ...[more]